We've found
13,253
archived clinical trials in
Arthritis
We've found
13,253
archived clinical trials in
Arthritis
A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects
Updated: 12/31/1969
Phase 4, Randomized, 52-Week Study To Evaluate Two Assessment Tools To Predict Treatment Success At 52 Weeks Based On A Treatment Decision At Week 12 In Subjects With Moderate To Severe Rheumatoid Arthritis Receiving Cimzia
Status: Enrolling
Updated: 12/31/1969
A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects
Updated: 12/31/1969
Phase 4, Randomized, 52-Week Study To Evaluate Two Assessment Tools To Predict Treatment Success At 52 Weeks Based On A Treatment Decision At Week 12 In Subjects With Moderate To Severe Rheumatoid Arthritis Receiving Cimzia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects
Updated: 12/31/1969
Phase 4, Randomized, 52-Week Study To Evaluate Two Assessment Tools To Predict Treatment Success At 52 Weeks Based On A Treatment Decision At Week 12 In Subjects With Moderate To Severe Rheumatoid Arthritis Receiving Cimzia
Status: Enrolling
Updated: 12/31/1969
A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects
Updated: 12/31/1969
Phase 4, Randomized, 52-Week Study To Evaluate Two Assessment Tools To Predict Treatment Success At 52 Weeks Based On A Treatment Decision At Week 12 In Subjects With Moderate To Severe Rheumatoid Arthritis Receiving Cimzia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Tritanium® Primary Acetabular Shell Study
Updated: 12/31/1969
A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
An Open Label Study for Participants With Rheumatoid Arthritis
Updated: 12/31/1969
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials